| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling
|
Rice, Shawn J.
|
|
2019
|
131 |
C |
p. 58-61
|
artikel
|
| 2 |
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases
|
Yin, Kai
|
|
2019
|
131 |
C |
p. 134-138
|
artikel
|
| 3 |
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project
|
Kerr, Keith M.
|
|
2019
|
131 |
C |
p. 95-103
|
artikel
|
| 4 |
Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer
|
Pérol, Maurice
|
|
2019
|
131 |
C |
p. 6-13
|
artikel
|
| 5 |
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)
|
Akamatsu, Hiroaki
|
|
2019
|
131 |
C |
p. 128-133
|
artikel
|
| 6 |
Comment on: Synchronous multiple non-small cell lung cancers in an allograft lung recipient
|
Gan, Christiaan Tji
|
|
2019
|
131 |
C |
p. 154
|
artikel
|
| 7 |
Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer
|
Lin, Chen
|
|
2019
|
131 |
C |
p. 62-68
|
artikel
|
| 8 |
Contents
|
|
|
2019
|
131 |
C |
p. v-vi
|
artikel
|
| 9 |
Corrigendum to “Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas” [Lung Cancer 126 (2018) 189–193]
|
Hu, Szu-Yen
|
|
2019
|
131 |
C |
p. 157-158
|
artikel
|
| 10 |
Editorial Board
|
|
|
2019
|
131 |
C |
p. iii
|
artikel
|
| 11 |
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study
|
Willén, Linda
|
|
2019
|
131 |
C |
p. 40-46
|
artikel
|
| 12 |
FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective
|
Quintanal-Villalonga, Alvaro
|
|
2019
|
131 |
C |
p. 112-121
|
artikel
|
| 13 |
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC
|
Bordi, Paola
|
|
2019
|
131 |
C |
p. 78-85
|
artikel
|
| 14 |
Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017
|
Takano, Natsuki
|
|
2019
|
131 |
C |
p. 69-77
|
artikel
|
| 15 |
Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma
|
Lim, Sun Min
|
|
2019
|
131 |
C |
p. 139-146
|
artikel
|
| 16 |
Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos
|
Maisonneuve, Patrick
|
|
2019
|
131 |
C |
p. 23-30
|
artikel
|
| 17 |
Lung cancer survivors and employment: A systematic review
|
Vayr, Flora
|
|
2019
|
131 |
C |
p. 31-39
|
artikel
|
| 18 |
Predictive value of a prognostic model based on pathologic features in lung invasive adenocarcinoma
|
Liu, Ao
|
|
2019
|
131 |
C |
p. 14-22
|
artikel
|
| 19 |
Response to comment on: ‘Synchronous multiple non-small cell lung cancers in an allograft lung recipient’
|
Pujol, Jean-Louis
|
|
2019
|
131 |
C |
p. 155-156
|
artikel
|
| 20 |
Significance of Tsukushi in lung cancer
|
Yamada, Tatsuya
|
|
2019
|
131 |
C |
p. 104-111
|
artikel
|
| 21 |
Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer
|
Yan, Sherry X.
|
|
2019
|
131 |
C |
p. 147-153
|
artikel
|
| 22 |
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance
|
O’Kane, Grainne M.
|
|
2019
|
131 |
C |
p. 86-89
|
artikel
|
| 23 |
The role of adjuvant therapy for atypical bronchopulmonary carcinoids
|
Wegner, Rodney E.
|
|
2019
|
131 |
C |
p. 90-94
|
artikel
|
| 24 |
Treatment, no treatment and early death in Danish stage I lung cancer patients
|
Christensen, Niels Lyhne
|
|
2019
|
131 |
C |
p. 1-5
|
artikel
|
| 25 |
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017
|
Lattuca-Truc, Mickaël
|
|
2019
|
131 |
C |
p. 122-127
|
artikel
|
| 26 |
Understanding patients’ values and preferences regarding early stage lung cancer treatment decision making
|
Sullivan, Donald R.
|
|
2019
|
131 |
C |
p. 47-57
|
artikel
|
Tijdschrift beschrijving